Abbott and WeightWatchers work together to help people with diabetes achieve their health goals

  • Two industry leaders join forces to empower people with diabetes by providing information and insights to improve weight loss, glycemic control and overall health
  • The collaboration will create a seamless, integrated experience between Abbott’s world-leading continuous glucose monitoring device1 and WeightWatchers’ number one doctor-recommended weight loss program2 to help individuals better understand and manage their diabetes and weight

ABBOTT PARKSick., August 4, 2022 /PRNewswire/ — Abbott (NYSE: ABT) and WW International, Inc. (“WeightWatchers” or “WW”) today announced a strategic partnership that will help people with diabetes better understand their diabetes and weight and deal with it. The companies are working together to integrate WeightWatchers’ diabetes-specific weight management program with Abbott’s FreeStyle Libre portfolio® Products to create a seamless mobile experience that gives people with diabetes the information and insights they need to make healthier diet adjustments, improve glucose levels and ultimately take more control of their health.

Maintaining a healthy weight and eating right are critical to living well with diabetes.3 However, for many people with diabetes, the most difficult part of diabetes management is determining what to eat and sticking to a meal plan.4 Through this partnership, participants will be able to receive glucose insights from Abbott’s sensor-based FreeStyle Libre technology that show the effects of food choices alongside those empirically validated5 WeightWatchers’ diabetes-focused nutritional advice to help you achieve your goals for a healthier lifestyle.

“We strive to put our customers at the heart of everything we do, and that includes building strategic partnerships with key industry leaders like WeightWatchers to deliver new services and offerings that can significantly improve the quality of life for people with diabetes,” said Jared Watkins, senior vice president of Abbott’s diabetes care business. “By combining our world-leading1 FreeStyle Libre Glucose Monitoring Technology with WeightWatchers #1 Physician Recommended Weight Loss Program,2 People with diabetes, particularly those with type 2 diabetes, who receive less intensive care from healthcare professionals can get the insights they need to take control of their health.”

The two companies will work together to enable Abbott’s FreeStyle Libre continuous glucose monitoring systems and the WeightWatchers mobile app to share information so people with diabetes can see their glucose data alongside WeightWatchers’ diabetes-tailored program.

“There is evidence that lifestyle changes, including changes in eating habits and activity routines, are a critical component of diabetes management and can help improve glycemic control,6” said Sima Sistani, CEO of WeightWatchers. “We’ve partnered with Abbott, a leader in diabetes care, to enable people with diabetes to achieve their weight and healthy lifestyle goals while still enjoying the foods they love and their glucose levels control better.”

The partnership will initially focus on solutions for people living with diabetes The United States in 2023.

About Abbott
Abbott is a leading global healthcare company that helps people live more fulfilling lives at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare with leading companies and products in diagnostics, medical devices, nutrition and branded generics. Our 113,000 colleagues serve people in more than 160 countries.

Connect with Abbott at, on LinkedIn at, on Facebook at and on Twitter @AbbottNews.

About WW International, Inc.
WeightWatchers is a people-centric technology company backed by the world’s leading commercial weight management program. For nearly six decades, we’ve inspired millions of people to adopt healthy habits for real life. Through our comprehensive tools, experienced coaches and community, members follow our proven, sustainable, science-backed program focused on weight loss. To learn more about the WeightWatchers approach to healthy living, please visit For more information about our global business, visit our corporate website at

Indications and important safety information

FreeStyle Libre 14-day system: Failure to use the FreeStyle Libre 14-Day System according to label directions may result in missing a serious low or high glucose event and/or treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick blood glucose reading to guide treatment decisions. If necessary, see a physician or contact Abbott at 855-632-8658 or for safety information.

FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre 2 or FreeStyle Libre 3 systems according to label directions may result in missing a serious low or high blood glucose event and/or making a treatment decision, resulting in injury. When glucose alarms and readings do not match symptoms or expectations, use a fingerstick glucose reading to make treatment decisions. If necessary, see a physician or contact Abbott at 855-632-8658 or for safety information.

1Data on file, Abbott Diabetes Care. Data is based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users of other leading sensor-based personal glucose monitoring systems.
2 Based on a 2020 IQVIA survey of 14,000 physicians recommending weight loss programs to patients.
3 Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS Jr. Nutritional therapy for adults with diabetes or prediabetes : A consensus report. diabetes treatment. 2019 May;42(5):731-754. doi: 10.2337/dci19-0014. Epub April 18, 2019. PMID: 31000505; PMC ID: PMC7011201.
4 American Diabetes Association. “5. Facilitating behavior change and well-being to improve health outcomes: Standards of medical care in diabetes – 2021.” Diabetes Care 44, No. Supplement 1 (2021): S53-S72.
5 Apolzan JW, LaRose JG, Anton SD, et al. A weight management program tailored for adults with type 2 diabetes: implications for glycemic control. Poster presented at: American Diabetes Association 82nd Scientific Sessions; 5th-6th June 2022; New Orleans, LA.
6 American Diabetes Association. Lifestyle Management: Standards of Medical Care in Diabetes – 2019. Diabetes Management. 2019;42(1):S46-S60.



Add a Comment

Your email address will not be published.